These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 17436860
21. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Tanimoto H, Nakata K, Nakamori Y, Nakatani T, Kusano N. Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076 [Abstract] [Full Text] [Related]
23. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008]. Yoshida I, Yamaguchi T, Kudo R, Fuji R, Takahashi C, Oota R, Kaku M, Kunishima H, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Fujita S, Matsuo S, Kono H, Asari S, Toyokawa M, Kusano N, Nose M, Horii T, Tanimoto A, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y. Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693 [Abstract] [Full Text] [Related]
26. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006]. Yamaguchi T, Yoshida I, Itoh Y, Tachibana M, Takahashi C, Kaku M, Kanemitsu K, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Baba H, Matsuo S, Asari S, Toyokawa M, Matsuoka K, Kusano N, Nose M, Murase M, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y. Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596 [Abstract] [Full Text] [Related]
28. [Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004]. Matsuzaki K, Watabe E, Furuki A, Kanayama A, Hasegawa M, Sato Y, Kobayashi I. Jpn J Antibiot; 2004 Dec; 57(6):475-80. PubMed ID: 15747585 [Abstract] [Full Text] [Related]
29. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2010)]. Goto H, Iwasaki M. Jpn J Antibiot; 2015 Apr; 68(2):85-104. PubMed ID: 26182813 [Abstract] [Full Text] [Related]
31. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2003 and March 2004]. Shinagawa N, Taniguchi M, Hirata K, Katsuramaki T, Mizukuchi T, Mashita K, Ushijima Y, Ushida T, Ishikawa S, Aikawa N, Yo K, Mizuno A, Takayama T, Sato T, Kato K, Kubo S, Suehiro S, Yura J, Fujimoto M, Manabe T, Takeyama H, Tanimura H, Taniguchi K, Hasegawa M, Yamaue H, Ohnishi H, Tanaka N, Iwagaki H, Kimura H, Tsumura H, Fuchimoto S, Yokoyama T, Sueda T, Takesue Y, Takeuchi H, Yasui Y, Hiyama E, Ikeda S, Yasunami Y. Jpn J Antibiot; 2006 Apr; 59(2):72-116. PubMed ID: 16805318 [Abstract] [Full Text] [Related]
32. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2011)]. Goto H, Iwasaki M. Jpn J Antibiot; 2015 Apr; 68(2):105-24. PubMed ID: 26182814 [Abstract] [Full Text] [Related]
33. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms]. Okubo T, Iyobe S, Fujiki Y, Sagai H. Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787 [Abstract] [Full Text] [Related]
39. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2006]. Yoshida I, Yamaguchi T, Itoh Y, Tachibana M, Takahashi C, Kaku M, Kanemitsu K, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Baba H, Matsuo S, Asari S, Toyokawa M, Matsuoka K, Kusano N, Nose M, Murase M, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y. Jpn J Antibiot; 2010 Dec; 63(6):457-79. PubMed ID: 21425597 [Abstract] [Full Text] [Related]
40. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]. Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T. Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]